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Background: Regulation of anoikis in human intestinal epithelial cells (IECs) implicates differentiation state-specific
mechanisms. Human IECs express distinct repertoires of integrins according to their state of differentiation.
Therefore, we investigated whether α2β1, α3β1, α5β1, and α6β4 integrins perform differentiation state-specific
roles in the suppression of IEC anoikis.
Results: Human (HIEC, Caco-2/15) IECs were exposed to specific antibodies that block the binding activity of
integrin subunits (α2, α3, α5, α6, β1 or β4) to verify whether or not their inhibition induced anoikis. The knockdown
of α6 was also performed by shRNA. Additionally, apoptosis/anoikis was induced by pharmacological inhibition of
Fak (PF573228) or Src (PP2). Anoikis/apoptosis was assayed by DNA laddering, ISEL, and/or caspase activity
(CASP-8, -9, or -3). Activation levels of Fak and Src, as well as functional Fak-Src interactions, were also assessed. We
report herein that differentiated IECs exhibit a greater sensitivity to anoikis than undifferentiated ones. This
involves an earlier onset of anoikis when kept in suspension, as well as significantly greater contributions from β1
and β4 integrins in the suppression of anoikis in differentiated cells, and functional distinctions between β1 and
β4 integrins in engaging both Fak and Src, or Src only, respectively. Likewise, Fak performs significantly greater
contributions in the suppression of anoikis in differentiated cells. Additionally, we show that α2β1 and α5β1
suppress anoikis in undifferentiated cells, whereas α3β1 does so in differentiated ones. Furthermore, we provide
evidence that α6β4 contributes to the suppression of anoikis in a primarily α6 subunit-dependent manner in
undifferentiated cells, whereas this same integrin in differentiated cells performs significantly greater contributions
in anoikis suppression than its undifferentiated state-counterpart, in addition to doing so through a dependence
on both of its subunits.
Conclusions: Our findings indicate that the suppression of human IEC anoikis implicates differentiation state-
selective repertoires of integrins, which in turn results into distinctions in anoikis regulation, and sensitivity,
between undifferentiated and differentiated IECs. These data further the functional understanding of the concept
that the suppression of anoikis is subjected to cell differentiation state-selective mechanisms.
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Cell-extracellular matrix (ECM) interactions play cru-
cial roles in the regulation of the various known cellular
processes [1-4]. The biological functions attributed to
cell-ECM interactions are mediated primarily by hetero-
dimeric (αβ) transmembrane receptors of the integrin
family [4-8]. So far, 18 α subunits and 8 β subunits have
been identified in humans, with α subunits non-
covalently associating with β subunits, consequently
forming 24 distinct heterodimeric (αβ) receptors with
differing ligand specificities [4-9]. Some α and β sub-
units can undergo post-transcriptional alternative
mRNA splicing, or post-translational proteolytic pro-
cessing [4-9]. This largely results in variants with alter-
ations in their cytoplasmic tails, thus adding further
versatility to their roles and functions [4-9]. It is those
integrins that have the β1 subunit in common which
constitute the majority of receptors for ECM compo-
nents [4-9]. Also of this group is the α6β4 integrin,
which is expressed exclusively in epithelial cells [4,6].
The binding of an integrin to its ECM ligand gener-
ates a vast range of transduction signals which affect
cell behavior, cell shape, and gene expression
[2,4,6,8-10]. To this effect, signaling by β1 integrins
owes largely to the recruitment and activation of the
tyrosine kinase Fak. In turn, Fak typically recruits and
activates the tyrosine kinase Src [1,2,4,8-12]. Conversely,
the α6β4 integrin engages Src, but not Fak [4,6,12,13]. Re-
gardless, integrin-mediated signal transduction involves
the downstream engagement of a plethora of pathways,
largely due to the formation of diverse signaling cassettes
through the recruitment by Fak, and/or Src, of an increas-
ing array of macromolecules [1,2,4,6,8-13]. In this respect,
it is established that a given repertoire of expressed integ-
rins not only engenders distinct signals for a specific cell
type, but also exerts a differential modulation of cell pro-
cesses within the same tissue [1-4,6,8-13].
Caspase-dependent apoptosis constitutes a finely reg-
ulated process which performs crucial functions in tis-
sue development and homeostasis [1,2,4,14,15]. It is
now well understood that normal cells are intrinsically
wired by default to undergo apoptosis and, conse-
quently, require the input of signals in order to main-
tain the process in a suppressed mode when not
warranted [1,2,4,14,15]. One of the critical biological
roles performed by cell-ECM interactions is the main-
tenance of cell survival [1,2,4,6,9,11-13,16,17]. To this
effect, normal cells undergo caspase-dependent apop-
tosis through a process termed anoikis (a.k.a. “detach-
ment-induced apoptosis”, or “integrin-mediated death”)
whenever a disruption, or loss, of integrin-mediated an-
chorage occurs [1,2,4,6,9,11-13,16-20]. Indeed, integrin
signaling, largely via the activation of Fak and/or Src,
leads to the engagement of numerous pathways thatpromote cell survival and the suppression of anoikis
[1,2,4,6,9-13,16-20].
The main distinction between apoptosis and anoikis
lies with the activation of CASP-8 as initiator caspase in
the latter [2,4,18-21], although such activation ultimately
leads to the activation of the common apoptotic initiator
CASP-9, in order to render the process irreversible
[2,4,18-20]. Like apoptosis, anoikis performs important
functions during organogenesis, as well as in tissue
maintenance and renewal [1,2,4,6,9,11-13,16,17,19,20].
In this respect, it is now recognized that normal cells are
endowed with a default anchorage-dependent surveil-
lance system, which is responsible for upholding the cor-
rect position of cells within their respective tissues, and
thereby sentencing to death-by-anoikis any cell that
would stray from its assigned position – by either inter-
acting with an inappropriately composed ECM, or by
losing anchorage altogether [1,2,4,9,16,17,19,20].
The intestinal epithelium is a useful physiological sys-
tem for understanding the functional connections
between integrin-mediated cell-ECM interactions and
the cell state [22-26]. The continuous renewal of this
simple columnar epithelium occurs along a well-defined
unit, the crypt-villus axis. This unit consists generally in
two cell populations: the proliferative, immature cells of
the crypt, and the differentiated cells of the villus
[22-28]. As part of the dynamic process of intestinal epi-
thelial cell (IEC) renewal, obsolete IECs typically enter
anoikis upon reaching the apex of the villi, as a means
of exfoliation [23,24,27,28]. For their part, crypt cells
occasionally undergo apoptosis in order to remove daugh-
ter cells that are damaged or defective [23,24,27,28]. Such
apparent contrast of destiny between undifferentiated and
differentiated IECs has been shown to implicate differenti-
ation state-related distinctions in the regulation of cell sur-
vival, apoptosis, and anoikis [4,23,24,29-37]. Incidentally,
crypt and villus IECs express differential profiles of integ-
rins as they interact with specific ECM components,
which are likewise deposited differentially, along the crypt-
villus axis [4,22-24,26,27]. Hence, the question remains
open as to whether such differentiation state-specific rep-
ertoires of integrins contribute distinctively in the regula-
tion of IEC anoikis.
In this study, we investigated the roles of the α2β1,
α3β1, α5β1 and α6β4 integrins in the suppression of
anoikis in undifferentiated (HIEC, Caco-2/15-2PC) and
differentiated (Caco-2/15 30PC) human IECs, including
with regards to their contributions in the activation of
Fak and/or Src. Herein, we show that differentiated
IECs exhibit a greater sensitivity to anoikis than undif-
ferentiated ones, when kept in suspension. To this
effect, we find that β1 and β4 integrin subunit-
containing integrins, as well as Fak, perform signifi-
cantly greater contributions in the suppression of
Beauséjour et al. BMC Cell Biology 2013, 14:53 Page 3 of 19
http://www.biomedcentral.com/1471-2121/14/53anoikis in differentiated cells. Additionally, we show
that the α2β1 and α5β1 integrins suppress anoikis in
undifferentiated cells only, whereas α3β1 does so exclu-
sively in differentiated ones. Furthermore, α6β4 per-
forms significantly greater contributions in the
suppression of anoikis, in differentiated cells. We also
provide evidence that α6β4 contributes to the suppres-
sion of anoikis in a primarily α6 subunit-dependent
manner in undifferentiated cells, whereas in differenti-
ated cells, this same integrin does so through a depend-
ence on both of its subunits. Taken together, our results
indicate that the suppression of human IEC anoikis im-
plicates differentiation state-selective repertoires of
integrins, which in turn results into distinctions in anoi-
kis regulation, and sensitivity, between undifferentiated
and differentiated IECs. Lastly, these findings further
the functional understanding of the concept that cell
survival, and the suppression of anoikis, are subjected
to cell differentiation state-selective mechanisms.
Results
Human IECs display a distinct sensitivity to anoikis
according to their state of differentiation
We first established a time-course appearance of
caspase-activated DNAse (CAD)-mediated DNA ladder-
ing, in both undifferentiated (HIEC and/or Caco-2/15
-2PC) and differentiated (Caco-2/15 30PC) IECs, main-
tained 0-24 h in suspension. In undifferentiated cells,
DNA laddering was weakly discernible around 8 h, in
order to increase in intensity to a maximum after 24 h
(Figure 1A), as we reported previously [30,32,33]. While
similar kinetics of DNA laddering were observed in dif-
ferentiated cells, we found that internucleosomal DNA
fragmentation became weakly discernible round the 4 h
time-point, instead of the 8 h one noted for their undif-
ferentiated counterparts (Figure 1A), as we previously
reported [30,32,33].
We then established the concomitant time-course
kinetics of the specific activities of the initiator caspases
CASP-8 and -9, as well as that of the executioner cas-
pase CASP-3 (which is responsible for the activation of
CAD [2,4,19,20]). In undifferentiated IECs, CASP-8
activity was weakly detectable around 2 h, thereafter
peaking around 8 h (Figure 1B). CASP-9 activity was
weakly detectable around 4 h and peaked around 12 h
(Figure 1B), indicating that its activation/activity
followed that of CASP-8, as expected [2,4,18-21,24]. In
turn, CASP-3 activity was likewise weakly detectable
around 4 h, increasing thereafter to a maximum around
the 24 h time-point (Figure 1B). Overall, the kinetics of
CASP-8, -9 and -3 activities paralleled that of the
appearance of internucleosomal DNA fragmentation
(Figure 1A-B). Of particular interest is the 8 h time-
point, where all three caspases began exhibiting strong-to-high activities, thus coinciding with the emergence of
discernible DNA laddering (Figure 1A-B). Although
similar kinetics of CASP-8, -9 and -3 activities were ob-
served in differentiated IECs, which likewise paralleled
that of the appearance of DNA laddering in these cells
(Figure 1A, C), we found that it was instead at the 4 h
time-point where all three caspases began exhibiting
strong-to-high activities (Figure 1C). Again, this coin-
cided with the emergence of discernible internucleoso-
mal DNA fragmentation (Figure 1A).
We have previously shown that the integrin-mediated
suppression of anoikis in human IECs engages Fak and
Src [29-33]. Hence, we analyzed the impacts of the
pharmacological inhibition of Fak and Src in both un-
differentiated and differentiated IECs, in relation to the
maintenance of these cells in suspension. Controls con-
sisted of adhering, non-treated cell cultures. As shown
in Figure 2A, the inhibition of Fak, Src, or the mainten-
ance in suspension, induced significant anoikis in both
undifferentiated and differentiated cells. Interestingly,
the inhibition of Fak, as well as the maintenance in sus-
pension, induced anoikis at significantly greater levels
in differentiated IECs. However, the inhibition of Src in-
duced apoptosis/anoikis without significant differences
between undifferentiated IECs and their differentiated
counterparts (Figure 2A).
The relative activation levels of Fak and Src were then
analyzed, in both control and treated cultures, in order
to validate the efficiency of our treatments. Additionally,
functional Fak-Src interactions were assessed by analyz-
ing the relative phosphorylation levels of the Y576/577
residues of Fak, enacted by Src [4,11,32-35]. As expected
[32-35], the inhibition of Fak in both undifferentiated
and differentiated IECs caused a significant down-
activation of Fak itself and of Src, along with a signifi-
cant decrease in Fak-Src interactions, as when cells were
kept in suspension (Figure 2B-E). In the same vein, the
inhibition of Src in both undifferentiated and differenti-
ated IECs resulted in its own down-activation and a sig-
nificant decrease in Fak-Src interactions, again as when
cells were kept in suspension (Figure 2B-D). Surpris-
ingly, while the inhibition of Src had no effect on the
activation of Fak in undifferentiated cells, it did result in
a significant down-activation of Fak in differentiated
ones (Figure 2B, E).
Therefore, these data altogether establish firmly that
differentiated human IECs exhibit a sensitivity to anoikis
that is distinct from their undifferentiated counterparts.
Additionally, these results not only show that such dif-
ferentiation state-distinctions are associated with specific
contributions from Fak and Src in suppressing anoikis,
but furthermore suggest a differentiation state-selective
crosstalk between Fak and Src, with regards to their
respective activation.
Figure 1 Human IECs exhibit differentiation state-associated distinctions in anoikis sensitivity. A. Representative (n≥ 3) time-course kinetics
of CAD-mediated DNA laddering from -2PC (Undifferentiated; lanes 1-5) and 30PC (Differentiated; lanes 6-10) Caco-2/15 cells maintained 0-24 h in
suspension, serum-free. L, 100-bp DNA size markers. B. Time-course kinetics (n≥ 3) of caspase activity for CASP-3 (filled diamonds), CASP-8 (open circles)
and CASP-9 (open squares), from -2PC Caco-2/15 cells maintained as in (A). C. Same as in (B), except that CASP-8, -9 and -3 activities were assessed
from 30PC Caco-2/15 cells maintained as in (A). A-B. Results obtained with HIEC cells were highly similar to those shown here for -2PC Caco-2/15 cells.
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Figure 2 Roles of Fak and Src in the suppression of anoikis in human IECs. A. HIEC (Undifferentiated; filled columns) and 30PC Caco-2/15
(Differentiated; open columns) adhering cell cultures were maintained 24 h serum-free (control) with PF573228 (Fak inhibitor) or PP2 (Src inhibitor),
or maintained instead in suspension. CASP-3 relative activity was then established, by comparison to controls. Results obtained with -2PC Caco-2/
15 cells were comparable to those shown here for HIEC cells. B. Representative (n≥ 5) WB analyses of the activation of Src and Fak, and
verifications of Fak-Src interactions, from -2PC (Undifferentiated) and 30PC (Differentiated) Caco-2/15 cell cultures maintained as in (A). Specific
antibodies for pY576/577p125Fak, pY418p60Src and pY397p125Fak, as well as for respective total protein forms, were used. C-E. -2PC (Undifferentiated;
filled columns) and 30PC (Differentiated; open columns) Caco-2/15 cells were maintained and processed as in (A-B), except that the relative
pY576/577 levels of Fak (C), as well as the relative activation levels of Src (D) and Fak (E), were established in comparison to controls. B-E. Results
obtained with HIEC cells were highly similar to those shown here for -2PC Caco-2/15 cells. A, C-E. Statistically significant (0.0001≤ P ≤ 0.001;
n≥ 5) differences between treated and control cultures are indicated by (*). Statistically significant (0.0005≤ P≤ 0.005; n ≥ 5) differences between
differentiated and undifferentiated IECs are indicated by (#).
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integrins in the suppression of anoikis in human IECs
To further understand mechanistically the differenti-
ation state-related distinctions in the regulation of anoi-
kis in human IECs, cells were exposed to specific mouse
monoclonal antibodies directed to the extracellular do-
main of the β1 (mAb P4C10) or β4 (mAb 3E1) integrin
subunits, in order to inhibit their binding activity. Con-
trols constituted of cell cultures exposed to mouse IgG’s
(control for blocking mAbs), or to no antibodies/IgG’s
(basal control). It must be noted here that human IECs
express the integrin subunits β1 and β4, regardless of
the state of differentiation [22,23,26,38]. However, un-
differentiated/crypt human IECs, but not differentiated/
villus ones, express a co-translational proteolysis-
processed β4 variant that lacks a small COOH-terminal
fragment in its cytoplasmic domain (dubbed “β4ctd−”)
[22,26,38].
As expected from our previous reports [29-32], the
exposure to IgG’s did not affect the survival of either un-
differentiated or differentiated IECs, as assessed by DNA
laddering (Figure 3A). The inhibition of the β1 integrin
subunit induced anoikis regardless of the state of differ-
entiation, although DNA laddering appeared more abun-
dant in differentiated IECs (Figure 3A). By contrast, the
inhibition of β4 did not affect the survival of undifferen-
tiated cells, whereas it induced anoikis in differentiated
ones (Figure 3A).
To further confirm these results, anoikis was instead
measured by ISEL, and the data from treated (blocking
mAbs or generic IgG’s) cultures were then compared to
those of basal (untreated) controls. Again, IgG’s did not
affect the survival of undifferentiated or differentiated
IECs (Figure 3B). However, the inhibition of β1 induced
cell death regardless of the state of differentiation
(Figure 3B). Additionally, such negative impact on cell
survival was significantly greater in differentiated cells
(Figure 3B), in keeping with the observed greater inten-
sity of DNA laddering (Figure 3A). Lastly, the inhibition
of β4 once again failed to affect the survival of undiffer-
entiated IECs, while producing significant cell death in
differentiated ones (Figure 3B).We then analyzed the relative activation levels of Fak
and Src, as well as functional Fak-Src interactions, in the
same treated and untreated cell cultures. As expected
[29,32], the exposure to IgG’s did not affect the activa-
tion of either Fak or Src, and did not influence Fak-Src
interactions (Figure 4A-D). However, the inhibition of
β1 resulted in a significant down-activation of both Fak
and Src, as well as in a significant decrease in Fak-Src
interactions, regardless of the state of differentiation
(Figure 4A-D). These effects were similar as those
observed when cells were maintained in suspension (see
previous section). By contrast, the inhibition of β4 did
not affect the activation of Fak in undifferentiated
or differentiated cells (Figure 4A, D), as expected
[4,6,12,13,29]. Interestingly, the inhibition of this subunit
did result in a significant down-activation of Src in dif-
ferentiated IECs only (Figure 4A, C), while at the same
time failing to affect functional Fak-Src interactions re-
gardless of the state of differentiation (Figure 4A-B).
Hence, these data altogether, along with those of the
previous section, indicate that β1 and β4 integrins per-
form distinct contributions in the suppression of IEC
anoikis not only according to the state of differentiation,
but also via their properties in engaging Fak and/or Src.
Differentiation state-distinct contributions of α2, α3, α5
and α6 integrin subunits in the suppression of anoikis in
human IECs
To further understand the differentiation state-distinct
contributions of the β1 and β4 integrin subunits in the
suppression of anoikis, IECs were exposed to specific
mAbs directed to the extracellular domains of the α2
(mAb P1E6), α3 (mAb P1B5), α5 (mAb P1D6), or α6
(mAb GoH3) integrin subunits, allowing for the inhib-
ition of their binding activities. Again, controls consti-
tuted of cultures exposed to mouse IgG’s, or to no
antibodies/IgG’s. It must be specified here that human
crypt IECs express predominantly the α2 and α5 integrin
subunits, with little or no α3, whereas villus cells express
predominantly the α3 integrin subunit, with little or no
α2 and α5 [22,23,39]. Accordingly, HIEC, undifferenti-
ated Caco-2/15 cells, and differentiated Caco-2/15 cells,
Figure 3 Differentiation state-distinct contributions of β1 and β4 integrins in the suppression of human IEC anoikis. A. Representative
(n≥ 3) CAD-mediated DNA laddering assays from HIEC (Undifferentiated) and 30PC Caco-2/15 (Differentiated) adhering cell cultures, maintained
24 h serum-free (control) with mouse IgG’s, P4C10 (β1 binding activity-blocking mAb), or 3E1 (β4 binding activity-blocking mAb). L, 100-bp DNA
size markers. B. HIEC (Undifferentiated; filled columns) and 30PC Caco-2/15 (Differentiated; open columns) cell cultures were maintained as in (A),
except that ISEL assays were performed and compared to controls. Statistically significant (0.0001≤ P ≤ 0.001; n≥ 6) differences between treated
and control cultures are indicated by (*). Statistically significant (0.0005≤ P ≤ 0.005; n ≥ 6) differences between differentiated and undifferentiated
IECs are indicated by (#). A-B. Results obtained with -2PC Caco-2/15 cells were highly similar to those shown here for HIEC cells.
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units that are similar to their in vivo crypt and villus
counterparts, respectively (Figure 5A-B). In any case, it
is known that the α2, α3 and α5 integrin subunits part-
ner with β1, in human IECs [4,22-24,26,27]. Conversely,
the α6 integrin subunit is expressed in human IECs re-
gardless of the state of differentiation (Figure 5A-B)
[39-41]. However, it partners exclusively with the β4
subunit and, consequently, constitutes the α6β4ctd- and
α6β4 receptors in undifferentiated/crypt and differenti-
ated/villus cells, respectively [22,23,26,39-41].
As assessed by ISEL, the inhibition of the α2 integrin
subunit induced significant cell death in undifferentiated
cells, but not in differentiated ones (Figure 6A, C). Like-
wise, the inhibition of α5 produced significant anoikis in
undifferentiated IECs only (Figure 6A-C). By contrast,
the inhibition of α3 induced significant cell death in
differentiated IECs, but not in undifferentiated ones
(Figure 6B-C). Finally, the inhibition of α6 produced
abundant anoikis regardless of the state of differentiation,although its impact to this effect was significantly greater
in differentiated cells (Figure 6A-C).
Taken altogether with our previous results regarding
the β1 and β4 integrin subunits, these data indicate that
the α2, α3, α5, and α6 subunits perform differentiation
state-selective contributions in the suppression of
human IEC anoikis not only according to their differen-
tiation state-associated expression, but also depending
on which β subunit (and variant) they are known to
partner with.
Differentiation state-distinct contributions of α2, α3, and
α5, in the engagement of Fak and Src by the β1 integrin
subunit, in the suppression of human IEC anoikis
Since the α2, α3, and α5 integrin subunits partner with
β1 in human IECs [4,22-24,26,27], we analyzed the rela-
tive activation levels of Fak and Src, as well as Fak-Src
interactions, following the mAb-mediated inhibition of
the binding activity of each of these three α subunits. In
undifferentiated cells, the inhibition of α2 and α5, but
Figure 4 Engagement of Fak and Src by β1 and β4 integrins in the suppression of human IEC anoikis. A. Representative (n≥ 4) WB
analyses of the activation of Src and Fak, and verifications of Fak-Src interactions, from -2PC (Undifferentiated) and 30PC (Differentiated) Caco-2/15
adhering cell cultures maintained 24 h serum-free (control) with mouse IgG’s, P4C10 (β1 binding activity-blocking mAb), or 3E1 (β4 binding
activity-blocking mAb). Specific antibodies for pY576/577p125Fak, pY418p60Src and pY397p125Fak, as well as for respective total protein forms, were
used. B-D. -2PC (Undifferentiated; filled columns) and 30PC (Differentiated; open columns) Caco-2/15 cell cultures were maintained and processed
as in (A), except that the relative pY576/577 levels of Fak (B), as well as the relative activation levels of Src (C) and Fak (D), were established in
comparison to controls. A-D. Results obtained with HIEC cells were highly similar to those shown here for -2PC Caco-2/15 cells. B-D. Statistically
significant (0.0001≤ P ≤ 0.001; n≥ 4) differences between treated and control cultures are indicated by (*). Statistically significant (0.0005≤ P ≤
0.005; n≥ 4) differences between differentiated and undifferentiated IECs are indicated by (#).
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Fak and Src, as well as in a significant decrease in Fak-
Src interactions (Figure 7A-D). By contrast, in differenti-
ated cells, the inhibition of α3, but not α2 or α5, resulted
in a significant down-activation of Fak and Src, as well
as in a significant decrease in Fak-Src interactions
(Figure 7A-D). Overall, these results further confirm theFigure 5 Differentiation state-distinct expression profiles of α2, α3, α5
(n≥ 3) WB (A) and RT-PCR (B) analyses of the expression of the α2, α3, α5
differentiated (Caco-2/15 30PC) adhering human IEC cultures, using specific
and mRNA (B).differentiation state-distinct contributions of α2, α3 and
α5 in the suppression of anoikis (Figure 6), in addition
to corroborating the results obtained following the
inhibition of Fak, of Src, and of the β1 subunit
(Figures 2, 3, 4).
Altogether, these data indicate that the α2β1, α3β1,
and α5β1 integrins perform differentiation state-selectiveand α6 integrin subunits, in human IECs. A-B. Representative
and α6 integrin subunits, in undifferentiated (HIEC, Caco-2/15 -2PC) and
antibodies (A) or primers (B). Actin was used as reference protein (A)
Figure 6 Differentiation state-distinct contributions of α2, α3, α5 and α6 integrin subunits, in the suppression of human IEC anoikis.
A. Representative (n≥ 3) double labeling-merged immunofluorescence micrographs of adhering HIEC cell cultures maintained 24 h serum-free
(control) with mouse IgG’s, P1E6 (α2 binding activity-blocking mAb), P1D6 (α5 binding activity-blocking mAb), or GoH3 (α6 binding activity-
blocking mAb). ISEL (green) was thereafter performed, with DAPI (blue) counter-staining of nuclei. B. Same as in (A), except that adhering 30PC
Caco-2/15 cells were maintained 24 h serum-free (control) with mouse IgG’s, P1B5 (α3 binding activity-blocking mAb), P1D6 (α5 binding activity-
blocking mAb), or GoH3 (α6 binding activity-blocking mAb). C. Adhering HIEC (Undifferentiated; filled columns) and 30PC Caco-2/15 (Differentiated;
open columns) cell cultures were maintained 24 h serum-free (control) with mouse IgG’s, P1E6, P1B5, P1D6, or GoH3. ISEL assays were performed
and compared to controls. Statistically significant (0.0001≤ P ≤ 0.001; n≥ 3) differences between treated and control cultures are indicated by (*).
Statistically significant (0.0005≤ P≤ 0.005; n ≥ 3) differences between differentiated and undifferentiated IECs are indicated by (#). A-B. Original
magnifications: 20X. A, C. Results obtained with -2PC Caco-2/15 cells were highly similar to those shown here for HIEC cells.
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Figure 7 Contributions of the α2, α3, and α5 integrin subunits in the engagement of Fak and Src, in human IECs. A. Representative (n≥ 3)
WB analyses of Src and Fak, and verifications of Fak-Src interactions, from adhering HIEC (Undifferentiated) and 30PC Caco-2/15 (Differentiated) cell
cultures maintained 24 h serum-free (control) with mouse IgG’s, P1E6 (α2 binding activity-blocking mAb), P1B5 (α3 binding activity-blocking mAb),
or P1D6 (α5 binding activity-blocking mAb). Specific antibodies for pY576/577p125Fak, pY418p60Src and pY397p125Fak, as well as for respective total pro-
tein forms, were used. B-C. HIEC (Undifferentiated; filled columns) and 30PC Caco-2/15 (Differentiated; open columns) cell cultures were maintained
and processed as in (A), except that the relative pY576/577 levels of Fak (B), as well as the relative activation levels of Src (C) and Fak (D), were
established in comparison to controls. A-D. Results obtained with -2PC Caco-2/15 cells were highly similar to those shown here for HIEC cells. B-D.
Statistically significant (0.0001 ≤ P≤ 0.001; n≥ 3) differences between treated and control cultures are indicated by (*). Statistically significant
(0.0005 ≤ P≤ 0.005; n≥ 3) differences between differentiated and undifferentiated IECs are indicated by (#).
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of human IEC anoikis.
Differentiation state-distinct contributions of α6 in the en-
gagement of Src by the β4 integrin subunit, in the sup-
pression of human IEC anoikis
As already noted, the α6β4ctd- and α6β4 integrins are
expressed in undifferentiated/crypt and differentiated/
villus cells, respectively [22,23,26,39-41]. Interestingly,
the α6β4ctd- receptor is non-functional for anchorage, as
ascertained by the inhibition of α6, β4, or both, in hu-
man IEC adhesion assays [38]. Thus, our findings in
these cells that the inhibition of β4 binding activity failed
to induce anoikis (Figure 3A-B), or impact significantly
on Src activation (Figure 4A, C), corroborated such a
lack of binding functionality for α6β4Actd-. However, our
additional findings that, in these same undifferentiated
IECs, the inhibition of α6 binding activity nevertheless
induced cell death (Figure 6A, C), constituted a contra-
diction to this effect.
We therefore analyzed the relative activation levels of
Fak and Src in undifferentiated and differentiated IECs,
following the inhibition of α6 binding activity. As always,
controls constituted of cultures exposed to mouse IgG’s,
or to no antibodies/IgG’s. In undifferentiated cells, the
inhibition of α6 caused a significant down-regulation ofSrc (Figure 8A, C), which was in line with its induction
of cell death (Figure 6A, C), but again in contradiction
with the failure of the inhibition of β4 to impact on
either parameters (Figure 3A-B, and Figure 4A, C).
However, the inhibition of α6 did not impact signifi-
cantly on functional Fak-Src interactions (Figure 8A-B),
or the activation of Fak itself (Figure 8A-B, D), as simi-
larly observed when β4 binding activity was inhibited
(Figure 4A, D).
In differentiated cells, α6 inhibition likewise caused a
significant down-activation of Src, while failing to affect
Fak-Src interactions, or Fak activation (Figure 8A-D).
However, these results in differentiated IECs were con-
sistent with those already obtained via the inhibition of
β4 (Figure 4A-D). Also, these agreed with regards to the
induction of anoikis in these same differentiated IECs,
when either α6 or β4 were inhibited (Figure 3A-B,
Figure 6B-C).
In an attempt to resolve the apparently enduring
inconsistencies in our results pertaining to each subunit
of α6β4ctd- in undifferentiated IECs, we opted for the
shRNA-mediated knockdown of α6 in these cells, using
a lentiviral approach of delivery. As shown in Figure 9A,
the shα6 we used caused a reduction in the expression
of the α6 subunit by at least 80%, as compared to when
cells were infected with a shCNS, or with GFP. We then
Figure 8 Contributions of the α6 integrin subunit in the engagement of Fak and Src, in human IECs. A. Representative (n≥ 3) WB analyses
of Src and Fak from adhering HIEC (Undifferentiated) and 30PC Caco-2/15 (Differentiated) cell cultures maintained 24 h serum-free (control) with mouse
IgG’s, or GoH3 (α6 binding activity-blocking mAb). Specific antibodies for pY576/577p125Fak, pY418p60Src and pY397p125Fak, as well as for respective total
protein forms, were used. B-D. HIEC (Undifferentiated; filled columns) and 30PC Caco-2/15 (Differentiated; open columns) cell cultures were maintained
and processed as in (A), except that the relative pY576/577 levels of Fak (B), as well as the relative activation levels of Src (C) and Fak (D), were
established in comparison to controls. A-D. Results obtained with -2PC Caco-2/15 cells were highly similar to those shown here for HIEC cells.
B-D. Statistically significant (0.0001 ≤ P ≤ 0.001; n ≥ 3) differences between treated and control cultures are indicated by (*).
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vival of undifferentiated IECs. As expected from our α6
inhibition studies (Figure 6A, C), the shα6 induced
significant anoikis in undifferentiated human IECs
(Figure 9B-C).
We also analyzed the relative activation levels of Fak and
Src, as well as Fak-Src interactions, following such knock-
down of α6. As expected from our α6 inhibition studies
(Figure 8A-B, D), the shα6 caused a significant reduction
of Src activation without impacting significantly on the
activation of Fak, or Fak-Src interactions (Figure 10).
Therefore, these data altogether indicate that both
α6β4ctd- and α6β4 contribute in the suppression of anoi-
kis via the engagement of a functional pool of Src that
does not interact with Fak and, therefore, which is dis-
tinct from the one engaged by β1 integrins. However,
these results also suggest that the contributions of
α6β4ctd- in the suppression of anoikis in undifferentiated
IECs appear to be primarily dependent on its α6 subunit,
whereas α6β4 enacts significantly greater contributions
than it’s anchorage non-functional counterpart in the
suppression of anoikis in differentiated IECs, in addition
to doing so through a dependence on both its α6 and β4
subunits.
Discussion
In the present study, we investigated the differentiation
state-specific roles of the α2, α3, α5, α6, β1, and β4integrin subunits in the suppression of IEC anoikis, in-
cluding with regards to their contributions in the activa-
tion of Fak and/or Src. Human undifferentiated/crypt
and differentiated/villus IECs express distinct repertoires
of integrins (and variants) [4,22-24,26,38-41]. Particu-
larly, undifferentiated IECs predominantly express α2β1,
α5β1 and α6β4ctd-, whereas differentiated ones predom-
inantly express α3β1 and α6β4 [4,22-24,26,38-41].
Herein, we report that differentiated IECs exhibit a
greater sensitivity to anoikis than undifferentiated ones.
This implicates an earlier onset of anoikis when kept in
suspension, as well as significantly greater contributions
from β1 and β4 integrins in the suppression of anoikis in
differentiated cells, and functional distinctions between
β1 and β4 integrins in engaging both Fak and Src, or Src
only, respectively. Accordingly, Fak performs signifi-
cantly greater contributions in the suppression of anoikis
in differentiated cells. We also show that α2β1 and α5β1
suppress anoikis in undifferentiated cells, whereas α3β1
does so in differentiated ones (Figure 11). Furthermore,
we provide evidence that α6β4ctd-, which is expressed in
undifferentiated IECs and is non-functional for anchor-
age [26,38-41], contributes nevertheless to the suppres-
sion of anoikis in a primarily α6 subunit-dependent
manner. Additionally, we show that α6β4, which is
expressed in differentiated cells and is anchorage-
functional [26,38-41], not only performs significantly
greater contributions than its anchorage non-functional
Figure 9 Impact of the knockdown of the α6 integrin subunit on the survival of human IECs. A. Representative (n≥ 3) WB analyses of α6
and actin from adhering HIEC cell cultures, following their infection by a lentivirus carrying GFP (control), shCNS or shα6. Specific antibodies for
α6 and actin were used. B. Adhering HIEC cell cultures were infected as in (A), except that ISEL assays were performed and compared to controls.
C. Adhering HIEC cell cultures were infected as in (A), except that CASP-3 relative activity was established, by comparison to controls. A-C. Results
obtained with -2PC Caco-2/15 cells were highly similar to those shown here for HIEC cells. B-C. Statistically significant (0.0001≤ P ≤ 0.001; n≥ 3)
differences between treated and control cultures are indicated by (*). Statistically significant (0.0005≤ P≤ 0.005; n ≥ 3) differences between shα6
and shCNS are indicated by (#).
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through a dependence on both of its subunits (Figure 11).
Hence, the suppression of human IEC anoikis implicates
differentiation state-selective repertoires of integrins,
which in turn results into distinctions in anoikis regula-
tion, and sensitivity, between undifferentiated and differ-
entiated IECs.
Our present study, coupled with our previous observa-
tions regarding human IEC survival and anoikis [29-37],
now firmly establish that differentiated/villus cells are
more sensitive to anoikis than their undifferentiated/
crypt counterparts. Such differentiation state-associated
distinctions likely constitute a major physiological
underpinning for the process of exfoliation-by-anoikis of
obsolete IECs, upon them reaching the apex of villi
[4,23,24,27,28,42]. This could also account for theobservations that mechanical/shearing forces in the in-
testine occasionally cause incidental anoikis in villus
cells only [42,43]. To this effect, our findings herein that
(α2, α3, α5)β1 and α6β4 integrins selectively contribute
to the suppression of IEC anoikis according to the state
of differentiation, in correlation with the differential ex-
pression profiles of these same integrins (and variants)
exhibited by crypt and villus cells [4,22-24,26,27,39],
identify integrins as the main functional determinants
for such differentiation state-associated sensitivity to
anoikis. This is further supported by the observations
that differentiated IECs are more sensitive to the inhib-
ition (and/or knockdown) of β1, α6, and β4 (this study;
[29-32]). Additionally, integrin-mediated cell polarization
and actin organization confer greater sensitivity to anoikis
[1,3,4,9,12,17-20,44,45], and differentiated/villus IECs are
Figure 10 Impact of the knockdown of the α6 integrin subunit on Fak and Src activation, in human IECs. A. Representative (n≥ 3) WB
analyses of Src and Fak, and verifications of Fak-Src interactions, from adhering HIEC cell cultures following their infection by a lentivirus carrying
GFP (control), shCNS or shα6. Specific antibodies for pY576/577p125Fak, pY418p60Src and pY397p125Fak, as well as for respective total protein forms,
were used. B. Adhering HIEC cell cultures were infected and processed as in (A), except that the relative pY576/577 levels of Fak (grey columns),
as well as the relative activation levels of Src (filled columns) and Fak (open columns), were established in comparison to controls. Statistically
significant (0.0001≤ P ≤ 0.001; n≥ 3) differences between treated and control cultures are indicated by (*). Statistically significant (0.0005≤ P ≤
0.005; n≥ 3) differences between shα6 and shCNS are indicated by (#). A-B. Results obtained with -2PC Caco-2/15 cells were highly similar to
those shown here for HIEC cells.
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undifferentiated/crypt counterparts [23,39,46-48]. In a
similar vein, α6β4-mediated hemidesmosome formation
and intermediate filament organization likewise confer
greater anoikis sensitivity [1,3,4,6,9,12,13,44,45], whereby
the anchorage functional α6β4-expressing villus cells bear
type II hemidesmosomes, and the anchorage non-
functional α6β4ctd--expressing crypt cells lack hemidesmo-
somes altogether [22,26,38,46,47]. However, it is note-
worthy that some integrins may not suppress anoikis, as
one would expect [1-4,9,16,17,20,27], but rather sensitize
cells to the process [4,19,20]. For instance, it was shown
recently that α8β1 is expressed in undifferentiated/crypt
IECs (but not in differentiated/villus ones), and that the
knockdown of the α8 subunit not only fails to impact
negatively on the survival of these cells, but actually con-
fers a measure of anoikis resistance to them [49]. Thus,
much remains to be understood of the regulatory determi-
nants that confer differentiation state-associated distinc-
tions in anoikis suppression and sensitivity, including
individual integrins themselves.
It is recognized that cell survival and death implicate
regulatory determinants that are distinct according not
only to the species and tissue, but also to the state of cell
differentiation [4,15,24,44]. So far, this concept has beenlargely verified in the human intestinal epithelium
[4,23,24,27,28,50,51]. For instance, IECs exhibit differen-
tiation state-distinct expression profiles of anti- and pro-
apoptotic Bcl-2 homologs, said profiles being established
during the differentiation process [29,50,52,53]. Add-
itionally, the expression of individual Bcl-2 homologs is
subjected to regulatory mechanisms that are specific ac-
cording to the differentiation status of IECs [29,34,37].
Such concept of differentiation state-distinct modula-
tions of cell survival and apoptosis inherently suggests
that the regulation of anoikis likewise implicates differ-
entiation state-specific determinants [4,24]. In the par-
ticular case of human IECs, several lines of evidence
now support this. As already highlighted above, human
IECs display differentiation state-related distinctions in
anoikis sensitivity, and this is associated with a differen-
tiation state-selective implication of integrins in the
regulation of anoikis. To that effect, the expression pro-
files of individual Bcl-2 homologs are affected distinct-
ively according to the state of differentiation, following
induction of anoikis by maintaining IECs in suspension
[29,34,37]. Additionally, differentiated cells exhibit lower
relative levels of activated Fak than undifferentiated ones
and, consequently, are more sensitive to its inhibition
(this study; [29-33,37]). In this respect, Fak impacts in a
Figure 11 Differentiation state-selective contributions of α2β1, α3β1, α5β1, and α6β4 integrins in the suppression of anoikis in human
IECs. Schematic drawing of an undifferentiated IEC (A) and its differentiated counterpart (B), illustrating how α2β1, α3β1, α5β1, and α6β4
integrins contribute in the engagement of Fak/Src signaling for the suppression of anoikis. A. In undifferentiated IECs, α2β1 and α5β1 (but not
α3β1) contribute in the engagement and activation of Fak (assessed by Y397 residue phosphorylation) via the classical requirement of both α
and β subunits for integrin functionality and signalling. Fak then engages and activates Src (assessed by Y418 residue phosphorylation) which, in
turn, enacts functional Fak-Src interactions (assessed by phosphorylation of Y576/577 residues of Fak). In parallel, α6β4ctd- engages and activates a
distinct pool of Src that does not interact functionally with Fak. Furthermore, such Src engagement by α6β4ctd- is enacted in a primarily α6
subunit-dependent manner. B. In differentiated IECs, α3β1 (but not α2β1 or α5β1) engages and activates Fak, again via the classical requirement
of both α and β subunits. Fak then engages and activates Src which, in turn, enacts functional Fak-Src interactions. However, in this context, Src
contributes reciprocally to Fak activation. In parallel, α6β4 engages and activates a distinct pool of Src that does not interact functionally with Fak.
Additionally, the engagement of Src by α6β4 is now enacted via the classical requirement of both α and β subunits. A-B. Such integrin subunit-
and differentiation state-selective roles of α2β1, α3β1, α5β1, and α6β4 integrins, in the engagement of Fak and/or Src, are likely to contribute to
the outcome of differentiated IECs being more sensitive to anoikis than their undifferentiated counterparts.
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of individual Bcl-2 homologs [29,34,37]. Although the
relative levels of activated Src are similar between undif-
ferentiated and differentiated cells, and consequently
show similar sensitivities to its inhibition (this study),
Src nonetheless impacts distinctively on the individual
expression of Bcl-2 homologs according to the state of
differentiation [4,32-34]. Furthermore, we have previ-
ously reported that although the integrin/Fak/Src
engagement of the MEK/Erk pathway is primarily Src-
dependent regardless of the state of human IEC differen-
tiation, this same pathway plays a marginal role (at best)in the suppression of anoikis in undifferentiated cells, as
opposed to its substantial roles to that effect in differen-
tiated ones [29,30,33,34,37]. Similarly, isoforms of the
PI3-K/Akt pathway perform differentiation state-distinct
roles in the integrin/Fak/Src-mediated regulation of
anoikis, in relation to their selective engagement by Fak,
or Src, and again according to the differentiation status
of human IECs [29-35,37]. Lastly, we have previously
demonstrated that the integrin/Fak/Src-mediated sup-
pression of anoikis in human IECs includes the inhib-
ition of the pro-apoptotic activation of p38βSAPK and
p38δSAPK in undifferentiated and differentiated cells,
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similar lines of evidence have been mounting from stud-
ies in other cell types [1,4,9,12,13,19,44,45], it is now
clear that the integrin-mediated control of anoikis is not
only tissue type- and species context-dependent, but also
differentiation state-selective.
In this respect, our observations that the inhibition of
Src does not impact on the activation of Fak in undiffer-
entiated cells while resulting in Fak’s down-activation in
differentiated ones (this study), coupled to those that
show a dependence on Fak for Src’s activation regardless
of the state of differentiation (this study; [32-35]), are
strongly suggestive of a differentiation state-distinct
crosstalk between Fak and Src with regards to their re-
spective activation (Figure 11). Signaling by β1 integrins
is typically initiated by the recruitment and activation of
Fak at the cytoplasmic tail of the β subunit. In turn, Fak
recruits and activates Src [1,2,4,8-12,16,17,20,54,55].
Conversely, Src may be first to be engaged, and then re-
cruit/activate Fak [4,11,54,55]. Although recent studies
point to the identity of individual integrins specifically
involved, as well to the intervention of integrin-
associated cytoplasmic molecules such as paxillin, talin
or filamin, much remains to be understood of the deter-
minants that dictate the order of engagement of Fak and
Src, as well as in defining their mutual dependence (or
not) for their activation [54,55].
On a related note, it is intriguing that the inhibition of
β1 integrins leads to the down-activation of Fak and Src,
along with a consequent drop in functional Fak-Src
interactions, whereas the inhibition of α6 and/or β4
down-activates Src without affecting Fak, or Fak-Src in-
teractions, regardless of the state of IEC differentiation
(this study; [32,34,35]). While these observations fall in
line with the current understanding that α6β4-mediated
signaling engages Src, whereas that of β1 integrins en-
gages both Fak and Src [1,2,4,8-13,16,17,20,26,54,55],
these nonetheless suggest the existence of separate, func-
tional pools of Src in human IECs – namely one engaged
by β1 integrins/Fak, and the other engaged by α6β4ctd-/
α6β4 (Figure 11). The existence of spatially and func-
tionally compartmentalized intracellular pools of signal-
ing molecules is now well recognized [4,8,11,56,57].
Incidentally, two other separate pools of Src, likewise in-
volved in the regulation of cell survival and/or anoikis,
have been previously identified in IECs: one associated
with E-cadherin junctional complexes [44,56,57], and
one associated with RTK signaling [33]. In the case of
the former, it remains to be fully understood how
E-cadherin-mediated Src signaling may crosstalk with
that of integrins (with Fak or not) [45,56,57]. In the case
of the latter, it is already established that extensive cross-
talk occurs between integrins and RTKs in the regulation
of virtually all known cell processes, often through Src[4,8,11,20,33,44,45,58]. Therefore, further studies are
warranted in order to better understand the underpin-
nings of the crosstalk between Fak and distinct func-
tional pools of Src, particularly with regards to the roles
of such crosstalk in the regulation of anoikis.
Another finding in the present study is that the α6β4
integrin expressed in undifferentiated IECs, which is
non-functional for anchorage and/or hemidesmosome
formation [26,38,40,41,47], contributes nevertheless to
the suppression of anoikis and does so primarily in an
α6-dependent manner (Figure 11). By contrast, the α6β4
integrin expressed in differentiated IECs not only enacts
significantly greater contributions than its anchorage
non-functional counterpart in the suppression of anoi-
kis, but does so through a dependence on its two sub-
units (Figure 11). Considering that this integrin is
functional for both anchorage and hemidesmosome for-
mation [26,38,40,41,47], it is therefore not surprising
that differentiated IECs are more sensitive to its inhib-
ition (whether via α6 or β4), or that its allosteric activa-
tion corresponds to the classical requirement of both α
and β subunits for integrin functionality and signaling
[5,7,8]. Incidentally, human IECs express the mRNA-
splicing cytoplasmic domain-variants α6A and α6B,
whereby undifferentiated/crypt cells express α6Aβ4ctd-
and differentiated/villus cells express α6Bβ4
[26,38,40,41]. To that effect, α6Aβ4ctd- has been shown
to promote proliferation in undifferentiated/crypt IECs
[40,41]. Hence, our observations that α6(A)β4ctd- en-
gages Src, and thus contributes to anoikis suppression in
undifferentiated IECs, constitutes an additional instance
of cell process-implication capacity for this integrin vari-
ant. Interestingly, the forced over-expression of α6B in
undifferentiated IECs leads to their growth arrest
[40,41]. Considering our observations regarding the α6
(A)-dependence for α6(A)β4ctd- in engaging Src and sup-
pressing anoikis in undifferentiated cells, as well as the
emerging evidence of signaling abilities by the α6 integ-
rin subunit [13,26,59], these data altogether raise further
the question of the variant-specific roles for α6A and
α6B in IEC processes – including in the suppression of
anoikis.
Lastly, although our use of binding activity-blocking
antibodies allowed for the discrimination of the impacts
of the inhibition of a given integrin subunit between
undifferentiated and differentiated IECs, these same bio-
logical tools did not allow for a similar discrimination
between the individual integrin subunits analyzed. This
is simply due to the inherent variability of efficiency
between the specific antibodies used. As examples, while
we were able to conclude with confidence that the inhib-
ition of α2β1 contributes to anoikis suppression in
undifferentiated cells only, it remains inconclusive
whether β1 integrins perform the greater roles in anoikis
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ant than α2β1 in the suppression of anoikis in undiffer-
entiated cells.
Conclusions
This study has provided evidence that distinctions in
anoikis susceptibility, between undifferentiated/crypt
and differentiated/villus IECs, implicate differentiation
state-selective repertoires of (α)β1 and α6β4 integrins
(and variants), which result into differentiation state-
distinctions in the overall regulation of human IEC anoi-
kis (Figure 11). In this respect, the present findings
altogether provide further functional understanding of
the concept that cell survival and suppression of anoikis
are subjected to differentiation state-selective mecha-
nisms. Additionally, we specifically identify the α2β1,
α5β1, and α6β4ctd- integrins as determinants of anoikis
regulation in undifferentiated IECs, as well as α3β1 and
α6β4 as comparable determinants in differentiated ones.
However, these findings in no way exclude similar impli-
cations for other integrins (and variants) that are
expressed by human IECs [22,23,26,39-41]. Further stud-
ies, along with the present findings, should provide a
greater understanding of the inherent complexities of
the integrin-mediated modulation of anoikis not only
within the context of normal tissue homeostasis, but




Specific antibodies directed against integrin subunits α2,
α3, α5 and α6, as well as against p125Fak, the phospho-
tyrosine397 activated form of p125Fak (pY397p125Fak), the
Src-phosphorylated tyrosine 576 and 577 residues of
p125Fak (pY576/577p125Fak), p60Src, the phosphotyro-
sine418 activated form of p60Src (pY418p60Src), and actin,
were used as described previously [29-38,40,41] and pur-
chased from Abcam (Cambridge, CA), Cell Signaling
Technology (Beverly, MA) and/or Millipore (Etobicoke,
ON, Canada). Other materials and reagents were pur-
chased from Sigma (Oakville, ON, Canada) and/or
Fischer Scientific (St-Laurent, QC, Canada), except
where otherwise specified.
Cell culture
Two established human IEC models, which are directly
relevant to human intestinal physiology and which allow
the accounting of the context of crypt Vs. villus IEC dif-
ferentiation status [26,29-35,37-41,46,48,49], were used
in the present study. The human intestinal epithelial
crypt (HIEC) cells are undifferentiated IECs that exhibit
the morphological and functional properties of in vivo
proliferative/undifferentiated human crypt IECs [46,48].Although HIEC cells undergo contact-growth inhibition
upon reaching confluence, they remain undifferentiated
[46,48]. Cells of the Caco-2/15 line undergo a full mor-
phological and functional differentiation process as a
monolayer, which takes place spontaneously once con-
fluence (0 days postconfluence; 0PC) has been reached,
and which is completed after 25–30 days [46]. Caco-2/15
cells were used herein either as subconfluent/undifferenti-
ated (−2PC) or postconfluent/fully differentiated (30PC)
cultures. HIEC, Caco-2/15 -2PC cells and Caco-2/15
30PC monolayers express integrin subunit repertoires,
and deposit ECM constituents in vitro, that correspond to
those observed in vivo for crypt and villus cells, respect-
ively (Figure 5) [26,38-41,46,48,49]. HIEC and Caco-2/15
cells were routinely cultured as we described previously
[29-35,37,38,40,41,49].
Integrin subunit binding activity-blocking assays
We used an established approach of integrin binding
activity inhibition in adhering cell cultures, using
integrin subunit-specific blocking antibodies (e.g.
[29-32,34,35,37,60]. This approach is further facilitated
by the physiological property of IECs to transcytose Igs
from their apical extracellular environment to their
basolateral one [23,25], thus enabling efficient access of
blocking antibodies to their targeted basal, already bind-
ing on naturally-deposited ECM, integrin subunits
[29-32,34,35,37]. Specific mouse monoclonal antibodies
used for blocking the binding activity of integrin sub-
units were the following: P1E6 (Millipore), which blocks
α2; P1B5 (Millipore), which blocks α3; P1D6 (Abcam),
which blocks α5; GoH3 (Cell Signaling), which blocks
α6 (A and/or B variants); P4C10 (Millipore), which
blocks β1; and 3E1 (Millipore), which blocks β4. These
antibodies have been extensively characterized/used in
numerous previous studies and are efficient at blocking/
inactivating their targeted integrin subunits, even when
already binding (e.g. [29-32,34,35,37,38,40,41,60]). As we
previously described [29-32,34,35,37], cell cultures were
maintained 24 h serum-free with 100 μg/ml of either
one of the blocking antibodies. Working concentrations
of the antibodies used were determined previously with
dose-response assays (not shown; e.g. [29-32,34,35,37,60]).
Non-treated cultures were considered as basal controls,
whereas cultures exposed instead to 100 μg/ml mouse
IgG’s (Sigma) represented controls for the blocking anti-
bodies, especially with regards to potential non-specific,
steric encumbrance/perturbation of already binding integ-
rins [29-32,34,35,37,38,40,41,60].
Pharmacological inhibition of Fak, Src activity assays
Cell cultures were maintained 24 h in medium without
serum (controls) or with i) 1 μM PF573228 (Tocris
Bioscience), for the specific inhibition of Fak; or ii)
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working concentrations of the inhibitors used were
determined previously with dose–response assays (not
shown; [32-35]). It is noteworthy that control cultures
included exposure to the same solvent as that used for
inhibitors and showed no significant differences with
cultures maintained in serum-free medium only (not
shown; [32-35]).
Anoikis assays
Anoikis was induced by keeping cells in suspension 0-
24 h, in serum-free medium. This was done by either
seeding freshly trypsinized undifferentiated cells onto
poly-2-hydroxyethyl methacrylate (polyHEMA)–coated
dishes, or by detaching intact monolayers of differenti-
ated cells by gentle flushing underneath the monolayer
with serum-free medium, as we previously described
[29-35,37].
CAD-mediated DNA laddering assays
DNA was isolated and the visualization of anoikis-
associated CAD-mediated internucleosomal DNA frag-
mentation (“DNA laddering”; [2, 4, 74]), on 2% agarose
gels (20 μg DNA/lane), was performed as we described
elsewhere [29-35,37]. Note that the method used for
DNA extraction employs Triton rather than SDS, thus
often leaving behind most intact genomic DNA
[29-35,37].
Reverse transcriptase-polymerase chain reaction (RT-PCR)
Total RNA extraction and subsequent RT-PCR were car-
ried out as described previously [30,31,35]. Specific
primers for the amplification of α2, α3, α5, α6 and actin
were purchased from Invitrogen Life Techologies (Grand
Island, NY). Controls for reactions were: a) DNA with-
out adding primers; and b) primers without adding DNA
(not shown) [30,31,35].
Caspase activity assays
Fluorometric caspase activity assays were performed as we
previously described [35]. Specific fluorogenic substrates
used were: benzyloxycarbonyl-Ile-Glu-Thr-Asp 7-amino-
4-trifluoromethylcouramin (Z-IETD-AFC; Calbiochem,
San Diego, CA), for CASP-8; acetyl-Leu-Glu-His-Asp
7-amino-4-trifuoromethylcouramin (Ac-LEHD-AFC; Cal-
biochem), for CASP-9; or acetyl-Asp-Glu-Val-Asp 7-
amino-4-methylcoumarin (Ac-DEVD-AMC; Calbiochem),
for CASP-3. For time-course kinetics, assays for each cas-
pase were performed from same cultures for each respect-
ive time-point. Reactions were read with a Hitachi S-2500
Spectrofluorometer, and caspase activity was expressed as
arbitrary units (AU) [35]. In other experiments, AU values
of treated cultures were compared to those of non-treated/control ones, X100, in order to establish the “cas-
pase relative activity” (expressed as “% of control”) [35].
ISEL assays
Coverslip-grown cell cultures were processed and in situ
terminal deoxynucleotidyl transferase (TDT)-mediated
dUTP nick-end labeling (ISEL) was carried out, as we pre-
viously described [29-37]. Evaluation of ISEL-positive
cells counterstained with 4′,6-diamidino-2-phenylindole
(DAPI) was performed as described elsewhere [29-35,37].
Typically, apoptotic indices were compared to those of
control cultures, X100 (expressed as “% of control”).
Western blotting (WB) and relative kinase activation
assays
Cell cultures were lysed in sample buffer (2.3% SDS, 10%
glycerol, and 0.001% bromophenol blue in 62.5 mM
Tris–HCl (pH 6.8) containing 5% β-mercaptoethanol)
and processed as we described previously [29-37]. Pro-
teins were resolved by SDS-PAGE (50 μg proteins/lane),
electrotransferred, and probed as we already described
[29-37]. Relative kinase activation analyses were per-
formed as described previously [28-33,39]. Typically,
immunoreactive bands were semi-quantified with Scion
Image (Scion) and the relative activated levels of kinases
were established with the ratios phosphorylated kinase/
total kinase, which in turn were compared to control
cultures, X100 (expressed as “% of control”).
sh (small hairpin) RNA-mediated expression silencing
assays
A commercially validated α6 (“shα6”, which silences the
expression of both the α6A and α6B variants; Sigma)
shRNA, as well as a CNS (control non-silencing;
“shCNS”; [49,61]) shRNA, were cloned into the lentiviral
expression vector pLentiNeoH1 (Invitrogen, Burlington,
ON). A cDNA coding for Green Fluorescent Protein
(GFP), cloned into the lentiviral expression vector pLen-
tiCMV, was purchased from Origene (Rockville, MD)
and used as indicator of infection efficiency. Lentivirus
production and harvesting was performed with HEK
(Human Embryonic Kidney) 293T cells, using the Vira-
Power Lentiviral packaging system (Invitrogen) accord-
ing to the manufacturer’s instructions. For lentiviral
infections, subconfluent (HIEC, Caco-2/15) cells were
incubated 48 h (37°C) with lentivirus suspensions con-
taining 4 μg/ml Polybrene (bromure hexadimethrin;
Sigma). Infected cultures were thereafter rinsed with
serum-free medium and further maintained 24 h serum-
free, before processing for analyses.
Data processing
Results and values shown represent mean ± SEM for at
least three (n ≥ 3) separate experiments and/or cultures.
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Student t test, with SigmaSTAT (Systat Software, San Jose,
CA). Data were compiled, analyzed and processed with
Excel (Microsoft, Redmond, WA). Except otherwise speci-
fied, images from blots, gels and scans were processed with
Vistascan (Umax Technologies, Fremont, CA), Photoshop
(Adobe, San Jose, CA) and PowerPoint (Microsoft).
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